2BB score and signals
Artiva Biotherapeutics, Inc.’s current 2BB score is 39 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 53 | Moderate |
| Momentum | 48 | Stable |
| Financial strength | 28 | Weak |
| Quality | 100 | Very Strong |
| Risk | 43 | Moderate |
Company facts
| Founded | 2019 |
| Employees | 115 |
| 52-week range | $2.22 – $14.53 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-10 | — | -0.5576 | — | $0.00 |
| 2026-08-27 | — | -0.6375 | — | $0.00 |
| 2026-05-08 | -0.95 | -0.8896 | $0.00 | $0.00 |
| 2026-03-10 | -0.85 | -0.8429 | $0.00 | $0.00 |
Related companies
2BBBullish & Bearish